BenevolentAI Investor Conference Presentation Deck

DISEASE EXPLORATION Understanding to build robust 000 40 000 disease biology hypotheses Target Endpoint: What we will measure Can we treat ALS by Sign reversing Autophagy impairment in microglia by reducing oxidative stress? Mechanism Cell type [T] Your biological question ... Provides an unprecedented view of the disease landscape Accelerates discovery of novel biology Surfaces potential targets and mechanisms that may not have otherwise been found Benevolent 9

View entire presentation